From: ironjustice on
This is age-related iron accumulation .. **acquired** .. porphyria
cutanea tarda ..

No .. "genetics" .. involved ..

Just plain old .. iron **accumulation** .. also known as ..

Porphyria Cutanea Tarda **Symptomatica**

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1928842

Can Med Assoc J. 1965 September 4; 93(10): 537–540. PMCID:
PMC1928842

Acquired Porphyria Cutanea Tarda
Report of a Case Successfully Treated by Phlebotomy
Andrew Koval, C. W. E. Danby, and H. Petermann
.
Abstrac
tCurrently, the porphyrias are classified in four main groups:
congenital porphyria, acute intermittent porphyria, porphyria cutanea
tarda hereditaria, and porphyria cutanea tarda symptomatica.
The acquired form of porphyria (porphyria cutanea tarda symptomatica)
occurs in older males and is nearly always associated with chronic
alcoholism and hepatic cirrhosis.
The main clinical changes are dermatological, with excessive skin
fragility and photosensitivity resulting in erosions and bullae.
Biochemically, high levels of uroporphyrin are found in the urine and
stools. Treatment to date has been symptomatic and usually
unsuccessful.
A case of porphyria cutanea tarda symptomatica is presented showing
dramatic improvement of both the skin lesions and porphyrin levels in
urine and blood following repeated phlebotomy.

Possible mechanisms of action of phlebotomy on porphyria cutanea tarda
symptomatica are discussed.


Who loves ya.
Tom


Jesus Was A Vegetarian!
http://tinyurl.com/634q5a


Man Is A Herbivore!
http://tinyurl.com/4rq595


DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk


From: ironjustice on
On Aug 23, 1:29 pm, "ironjust...(a)aol.com" <ironjust...(a)aol.com>
wrote:excessive skin fragility and photosensitivity resulting in
erosions and bullae <<

The association between iron overload and iron deficiency seems to
be .. paradoxal.
Hemolytic anemia is diagnosed just before she .. is .. dead .. it
seems.

Rapidly progressing purpuric lesions to massive hemorrhagic bullae,
with rapid improvement by Prednisolon as a coetaneous manifestation of
Systemic Lupus Erythematosus: a case report.
Khorvash FF, Emami Naeini AA, Behjati MM, Karimifar MM, Khorvash FF,
Dialami KK
Cases J 2008 Aug 8; 1(1):79.

ABSTRACT:
BACKGROUND:
Systemic lupus Erythematosus is a chronic autodestructive disease,
with loss of immune tolerance to nucleic acid and other cross reactive
antigens. Despite of the numerous studies, the presence of some new
manifestations indicates the greater proportion of unknown data.
CASE PRESENTATION:
Our case, is a 26-year-old female, by the chief complaint of headache,
vomiting, fever and arthralgia.
Some hemorrhagic ulcers in her mouth with fulminant pethechia/purpura
on her limbs and buttocks were prominent.
On admission, she was in hypotensive state.
By the clinical suspicion to meningococcal septicemia, lumbar puncture
was performed, and antibiotic therapy was started.
Cerebrospinal fluid was normal.
Suddenly, on the 3rd day of admission, hemorrhagic bullae were evolved
from those purpuric lesions.
Leukocytosis, immune hemolytic anemia, thrombocytopenia and high
antinuclear antibody/double stranded DNA level and hypocomplemania
were present simultaneously.
In skin biopsy, immune complex deposition in dermoepidermal junction
was seen. The diagnosis of Systemic lupus Erythematosus was made.
The patient responded well to corticosteroid therapy.
CONCLUSION:
Coetaneous manifestations are very common in Systemic lupus
Erythematosus, and help the physician making differential diagnoses
and proper diagnosis.
The rapidly evolving hemorrhagic bulla from primary purpuric lesions,
with rapid response to Prednisolon, is a rare manifestation of
Systemic lupus Erythematosus, which should be considered in such a
disease setting.
Cases journal [Cases J]
--------------------------------------------------------------------------------

Porphyria cutanea tarda in pre-existent lupus erythematosus - is there
an association?
van Tuyll van Serooskerken AM, Habets JM, Badeloe S, Poblete-Gutiérrez
P, Frank J
Int J Dermatol 2007 Nov.:50-2.

In lupus erythematosus (LE), vesicles and bullae are only rarely
seen.
However, in some instances such efflorescences might suggest an
association with distinct cutaneous diseases, including erythema
multiforme, toxic epidermal necrolysis or autoimmune blistering
disorders such as bullous pemphigoid, pemphigus vulgaris, and
dermatitis herpetiformis Duhring.
Another blistering disease that has been described in association with
cutaneous and systemic LE is porphyria cutanea tarda (PCT).
PCT is a metabolic disorder caused by a deficiency of the fifth enzyme
in heme biosynthesis, uroporphyrinogen decarboxylase.
Here, we report on a 57-year-old Caucasian woman of Dutch origin with
a medical history of mild cutaneous LE who developed skin fragility,
blistering skin lesions, milia, and facial hypertrichosis.
Subsequent porphyrin analysis in urine and feces confirmed the
suspected simultaneous manifestation of LE and PCT.


Who loves ya.
Tom


Jesus Was A Vegetarian!
http://tinyurl.com/634q5a


Man Is A Herbivore!
http://tinyurl.com/4rq595


DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk

From: jay on
> This is age-related iron accumulation .. **acquired** .. porphyria
> cutanea tarda ..
>
> No .. "genetics" .. involved ..

Non-ahr gene susceptibility Loci for porphyria and liver injury
induced by the interaction of 'dioxin' with iron overload in mice.
Among the actions of 2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin) in
mice is the induction of hepatic porphyria. This is similar to the
most common disease of this type in humans, sporadic porphyria cutanea
tarda (PCT). Evidence is consistent with the actions of dioxin being
mediated through binding to the aryl hydrocarbon receptor (AHR) with
different Ahr alleles in mouse strains apparently accounting for
differential downstream gene expression and susceptibility. However,
studies of dioxin-induced porphyria and liver injury indicate that the
mechanisms must involve interactions with other genes, perhaps
associated with iron metabolism. We performed a quantitative trait
locus (QTL) analysis of an F(2) cross between susceptible C57BL/6J
(Ahr(b1) allele) and the highly resistant DBA/2 (Ahr(d) allele)
strains after treatment with dioxin and iron. For porphyria we found
QTLs on chromosomes 11 and 14 in addition to the Ahr gene (chromosome
12). Studies with C57BL/6.D2 Ahr(d) mice confirmed that the Ahr(d)
allele alone did not completely negate the response. SWR mice are
syngenic for the Ahr(d) allele with the DBA/2 strain but are
susceptible to porphyria after elevation of hepatic iron. Analysis of
SWRxD2 F(2) mice treated with iron and dioxin showed a QTL on
chromosome 11, as well as finding other loci on chromosomes 1 (and
possibly 9), for both porphyria and liver injury. These findings show
for the first time the location of genes, other than Ahr, that
modulate the mechanism of hepatic porphyria and injury caused by
dioxin in mice. Orthologous loci may contribute to the pathogenesis of
human sporadic PCT. PMID: 11854449
From: ironjustice on
On Aug 25, 4:28 pm, jay <jaym1...(a)hotmail.com> wrote: snip <<

One might wonder what you are doing on a thread about NON GENETIC
porphyria .. ?

Seems your .. contribution is rife with .. genes .. ?

There are a number of different porphyria cutanea tardas .. and the
REST have .. genes involved ..

Why don't you stick with .. genetics .. WHEN you post your ..
genetic .. susceptibility .. ?

Because .. ?

You don't know the difference between non genetic or .. genetic .. ?

That could be it couldn't it .. jay ..

You may be too stupid to realize what you post .. ?

You haven't really showed any kind of intelligence .. yet ..

Why don't you keep your stupidity .. confined .. to your OWN
threads ..


Who loves ya.
Tom


Jesus Was A Vegetarian!
http://tinyurl.com/634q5a


Man Is A Herbivore!
http://tinyurl.com/4rq595


DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk




> > This is age-related iron accumulation .. **acquired** .. porphyria
> > cutanea tarda ..
>
> > No .. "genetics" .. involved ..
>
> Non-ahr gene susceptibility Loci for porphyria and liver injury
> induced by the interaction of 'dioxin' with iron overload in mice.
> Among the actions of 2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin) in
> mice is the induction of hepatic porphyria. This is similar to the
> most common disease of this type in humans, sporadic porphyria cutanea
> tarda (PCT). Evidence is consistent with the actions of dioxin being
> mediated through binding to the aryl hydrocarbon receptor (AHR) with
> different Ahr alleles in mouse strains apparently accounting for
> differential downstream gene expression and susceptibility. However,
> studies of dioxin-induced porphyria and liver injury indicate that the
> mechanisms must involve interactions with other genes, perhaps
> associated with iron metabolism. We performed a quantitative trait
> locus (QTL) analysis of an F(2) cross between susceptible C57BL/6J
> (Ahr(b1) allele) and the highly resistant DBA/2 (Ahr(d) allele)
> strains after treatment with dioxin and iron. For porphyria we found
> QTLs on chromosomes 11 and 14 in addition to the Ahr gene (chromosome
> 12). Studies with C57BL/6.D2 Ahr(d) mice confirmed that the Ahr(d)
> allele alone did not completely negate the response. SWR mice are
> syngenic for the Ahr(d) allele with the DBA/2 strain but are
> susceptible to porphyria after elevation of hepatic iron. Analysis of
> SWRxD2 F(2) mice treated with iron and dioxin showed a QTL on
> chromosome 11, as well as finding other loci on chromosomes 1 (and
> possibly 9), for both porphyria and liver injury. These findings show
> for the first time the location of genes, other than Ahr, that
> modulate the mechanism of hepatic porphyria and injury caused by
> dioxin in mice. Orthologous loci may contribute to the pathogenesis of
> human sporadic PCT. PMID: 11854449